Biocon Postal Ballot Notice for Director Appointments and Preferential Issue

Biocon seeks shareholder approval via postal ballot for 10 resolutions including director appointments and a preferential share issue.
Key proposals include revising Kiran Mazumdar-Shaw's remuneration to ₹21 crore and appointing Shreehas Tambe as CEO & MD.
The company proposes issuing 8.79 million shares at ₹376.16 each to acquire minority stakes in subsidiary Biocon Biologics.
Remote e-voting period runs from May 9 to June 7, 2026, with results to be declared by June 9, 2026.